Alignment Healthcare (NASDAQ:ALHC – Get Free Report) and biote (NASDAQ:BTMD – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, analyst recommendations, institutional ownership, dividends, valuation and profitability.
Volatility & Risk
Alignment Healthcare has a beta of 1.14, indicating that its share price is 14% more volatile than the S&P 500. Comparatively, biote has a beta of 1.69, indicating that its share price is 69% more volatile than the S&P 500.
Analyst Recommendations
This is a summary of current recommendations for Alignment Healthcare and biote, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Alignment Healthcare | 0 | 4 | 7 | 0 | 2.64 |
| biote | 1 | 1 | 1 | 1 | 2.50 |
Valuation & Earnings
This table compares Alignment Healthcare and biote”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Alignment Healthcare | $3.95 billion | 0.46 | -$720,000.00 | $0.19 | 45.84 |
| biote | $192.22 million | 0.22 | $27.05 million | $0.11 | 10.64 |
biote has lower revenue, but higher earnings than Alignment Healthcare. biote is trading at a lower price-to-earnings ratio than Alignment Healthcare, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
86.2% of Alignment Healthcare shares are held by institutional investors. Comparatively, 21.7% of biote shares are held by institutional investors. 5.2% of Alignment Healthcare shares are held by company insiders. Comparatively, 32.4% of biote shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Profitability
This table compares Alignment Healthcare and biote’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Alignment Healthcare | 0.89% | 20.02% | 3.46% |
| biote | 3.19% | -22.33% | 12.10% |
Summary
Alignment Healthcare beats biote on 9 of the 15 factors compared between the two stocks.
About Alignment Healthcare
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
About biote
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.
Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
